[Neutropenia and hypotension during treatment with recombinant human erythropoietin in refractory anemia with ring sideroblasts].
Benzadón
R J
RJ
Gurfinkel
E P
EP
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000756:Anemia, Sideroblastic / Q000150:complications / Q000188:drug therapy*; D004921:Erythropoietin / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D011994:Recombinant Proteins / Q000009:adverse effects; D012084:Renin-Angiotensin System / Q000187:drug effects
D011994:Recombinant Proteins; D004921:Erythropoietin
Neutropenia e hipotension durante el tratamiento con eritropoyetina humana recombinante de una anemia refractaria con sideroblastos en anillo.